Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000617683 | SCV000737930 | uncertain significance | Cardiovascular phenotype | 2017-03-11 | criteria provided, single submitter | clinical testing | The p.L2623P variant (also known as c.7868T>C), located in coding exon 52 of the RYR2 gene, results from a T to C substitution at nucleotide position 7868. The leucine at codon 2623 is replaced by proline, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |